18 July 2024

Breast cancer: first scientifically validated guidelines on the usefulness of the imaging exam known as FDG PET/CT

Experts from two international nuclear medicine societies (EANM and SNMMI) have joined those from important societies of various other medical specialities involved in the care of breast cancer patients – including oncology, surgery, radio-oncology and breast imaging – to draw up a set of recommendations, based on scientific evidence, on the correct utilisation, in breast cancer, of a medical imaging exam. The exam in question has been used for several years and involves radioactive substances, in this case a glucose analogue called fluorodeoxyglucose (FDG).

17 Jul. 2024

Postdoc at the Immunophysiology Lab

Research
Application Starts: 17 Jul. 2024
Application Ends: 30 Sep. 2024

Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a Postdoc to join our team at the Champalimaud Research Program.  

11 Jul. 2024

2 Postdoctoral Fellows at Tissue Immunity Lab

Research
Application Starts: 11 Jul. 2024

Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a 2 Postdocs to join our team at the Champalimaud Research Program. 

The selected candidate will:

The position

09 July 2024

Four Researchers in Portugal Elected as EMBO Members

Now, Megan Carey from the Champalimaud Foundation (CF), Mónica Sousa from the Instituto de Investigação e Inovação em Saúde (i3S), Ricardo Henriques from the Instituto Gulbenkian de Ciência (IGC), and Rui Oliveira from IGC and the Instituto Universitário de Ciências Psicológicas Sociais e da Vida (ISPA), become EMBO Mem

Innovative High-throughput Approaches to Understanding and Combating Cancer

Host

Adriana Sánchez Danés, Principal Investigator, Champalimaud Research


Venue

Seminar room


Abstract

To overcome the complexities of cancer and pave a path towards a cure, the McManus Lab is developing innovative approaches that consider both the genetic drivers of the disease and its interactions within the cellular environment. Join Dr. McManus to explore new technologies and methods to combat this multifaceted complex human disease.

27 June 2024

Gender equality: one step forward, two steps back?

Given that nursing is mostly a female profession, why are management positions mostly held by men?
 
The question was asked by Carla Martins, director of nursing at the Local Health Unit of Santa Maria Hospital, in Lisbon, during a recent debate at the Champalimaud Foundation (CF) on gender equality and, more specifically, on female leadership in healthcare.
 

Less Heat, More Light: Discovering Smarter Therapies for Pediatric Brain Tumors

Host

Adriana Sánchez Danés, Principal Investigator, Champalimaud Research


Venue

Seminar room

Tracing the origins of cancer: a stem cell perspective

Host

Adriana Sánchez Danés, Principal Investigator, Champalimaud Research


Venue

Seminar room

20 June 2024

New CAML PhD Program in Surgical Oncology Research

This innovative programme is designed to develop future leaders in surgical oncology by combining cutting-edge scientific research with advanced surgical training. It offers a comprehensive and flexible doctoral curriculum for surgical residents, certified surgeons, and cancer-focused gastroenterologists and oncologists.

19 June 2024

What can be said about the future of artificial intelligence?

Artificial intelligence (AI) is a spectacular tool that has been in development for the last decades; its role in our lives is already pervasive and will inevitably grow; and, most importantly, we can, through regulation, avoid its abuses (such as fake news and the manipulation of human beings). Indeed, whatever the future of AI is to be, we have the power to choose – wisely – to use it for the common good.

Subscribe to Cancer
Loading
Please wait...